Guy Braunstein
Director/Board Member chez Actelion Clinical Research, Inc.
Fortune : 612 125 $ au 31/03/2024
Profil
Guy Braunstein is currently the Director at Actelion Clinical Research, Inc. He previously held positions as the Director-Europe Development & Medical Affairs at Chiron Corp., Medical Director at Fisons Pharmaceuticals, Executive VP & Head-Global Clinical Development at Actelion Ltd., and Chief Medical Officer at Merck Serono SA. He also worked at Serono International SA as a Chief Medical Officer.
Dr. Braunstein is currently the Chief Medical Officer & Executive Vice President at Idorsia Ltd.
He holds a doctorate degree from Université Paris 1 Panthéon-Sorbonne.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IDORSIA LTD.
0,10% | 31/12/2022 | 194 958 ( 0,10% ) | 612 125 $ | 31/03/2024 |
Postes actifs de Guy Braunstein
| Sociétés | Poste | Début |
|---|---|---|
| Actelion Clinical Research, Inc. | Director/Board Member | - |
Anciens postes connus de Guy Braunstein
| Sociétés | Poste | Fin |
|---|---|---|
| IDORSIA LTD | Chief Tech/Sci/R&D Officer | 31/03/2024 |
| ACTELION | Corporate Officer/Principal | 01/01/2017 |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Corporate Officer/Principal | 01/01/2009 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/2003 |
| Fisons Pharmaceuticals | Corporate Officer/Principal | 01/01/1996 |
Formation de Guy Braunstein
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IDORSIA LTD | Health Technology |
| Entreprise privées | 6 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
| Fisons Pharmaceuticals | |
| Serono International SA | |
| Actelion Clinical Research, Inc. |
